Mellozzan (Melatonin)

Melatonin in Mellozzan binds to MT1 and MT2 receptors in the brain’s suprachiasmatic nucleus. This receptor activation mimics the body’s natural nighttime hormone signal, reducing neuronal activity that promotes wakefulness and thereby facilitating the onset of sleep and stabilising circadian rhythms.

The appropriate dose of Mellozzan is determined by the prescribing healthcare professional based on the individual’s age, condition, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for melatonin use in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before starting Mellozzan.

To order Mellozzan, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mellozzan differs from prescription hypnotics such as benzodiazepines or Z‑drugs because it works by restoring the natural melatonin signal rather than directly depressing the central nervous system. This generally results in fewer next‑day residual effects, but efficacy may be modest for severe insomnia where stronger agents are sometimes required.

Mellozzan should be stored below 25 °C in its original packaging, protected from moisture and direct sunlight. Keep the product out of reach of children and do not use it after the expiration date printed on the label.

Mellozzan is taken orally, usually with a glass of water. For best results, it is commonly recommended to take the product 30‑60 minutes before the desired bedtime, following the dosing instructions provided by the prescriber.

Serious but rare risks include allergic reactions such as rash, itching, swelling or difficulty breathing, as well as mood alterations like worsening depression or anxiety. Hormonal disturbances, such as changes in menstrual cycles, have also been reported. Any of these symptoms should prompt immediate medical evaluation.

Mellozzan should be avoided by individuals with known hypersensitivity to melatonin or any excipients in the formulation. People taking certain anticoagulants, immunosuppressants, or those with uncontrolled psychiatric disorders should consult a healthcare professional before use.